Home Archive October 2019 Bio Business Antidepressant Approvals Could Herald New Era in Psychiatric Drugs The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development. Oct 1, 2019 BIANCA NOGRADY 1K ABOVE: © ISTOCK.COM, MARTIN BARRAUD As droughts go, the one plaguing...
Tag: <span>antidepressant</span>
Post
Dual Antiplatelet Therapy After Minor Stroke, TIA
by Judy George, Senior Staff Writer, MedPage Today August 20, 2019 Dual antiplatelet therapy should be started within 24 to 48 hours of high-risk transient ischemic attack (TIA) or minor ischemic stroke and continued for 21 days, a pooled analysis of the CHANCE and POINTtrials found. Clopidogrel-aspirin treatment started quickly reduced the risk of major...
Post
Ketamine may not be an actual antidepressant, but may decrease the burden of symptoms
by Journal of Psychotherapy and Psychosomatics A new study indicates that the antidepressant effects of ketamine may not be such, according to a paper published in Psychotherapy and Psychosomatics. The study investigates the hypothesis that depressed individual receiving ketamine infusions, associate feelings of lightness and floating which are a typical occurrence in the use of...
Post
Research pushes back on benefits of compounded topical pain creams
Marketed and prescribed for a variety of muscle and nerve conditions, compounded topical pain creams and gels work about as well as placebos, study shows JOHNS HOPKINS MEDICINE In an effort to reduce chronic pain, many people look for hope by paying $20 to thousands of dollars for a tube of prescription topical pain cream or gel. Now, results of...
Post
Major depression: Existing drug reduces symptoms by 45 percent
For the first time in decades, researchers have identified a new medication that can successfully treat major depression. Depression affects about 300 million people across the globe, making the condition the “leading cause of ill health and disability worldwide,” according to the World Health Organization (WHO). Image: An existing oral drug may relieve major depression. In 2016 in the United States, over...
Post
New research: Ketamine activates opioid system to treat depression
Experts caution against widespread use due to a potential for tolerance, abuse, and dependence AMERICAN PSYCHIATRIC ASSOCIATION Washington, D.C., — A new study appearing online today from the American Journal of Psychiatry finds that ketamine’s acute antidepressant effect requires opioid system activation, the first time that a receptor site has been shown in humans to be necessary...
Post
Building an Antidepressant Diet
Researchers find that eating these foods can reduce depression. A recent study in BMC Medicine has found that changing your diet could significantly improve your mood. The link between food and mood is part of an emerging field of psychiatry called “nutritional psychiatry.” There is growing scientific evidence that what we eat significantly impacts our emotions and well-being. The randomized controlled study of 67 participants examined the...
Post
Breakthrough study finds new mechanism explaining ketamine’s antidepressant effects
A team at the University of Illinois at Chicago has uncovered a new mechanism that helps explain the remarkably rapid, and long-lasting, antidepressant effects of the controversial drug ketamine. The exciting research reveals the drug operates in a similar way to conventional SSRI antidepressants, except is it significantly more effective. The same mechanism explaining how SSRI antidepressants function...